Collectively, our findings demonstrate that the ALG3-FOXD1 axis enhances mitophagy by transcriptionally activating BNIP3 expression, thereby promoting NPC progression and modulating the response of NPC cells to gemcitabine. This evidence concerns the gene FOXD1 and nasopharyngeal carcinoma.